Related Experiment Video
Updated: Aug 16, 2026

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
Published on: November 28, 2025
Thiamine-responsive congenital lactic acidosis: clinical and biochemical studies
Mitsuo Toyoshima1, Akira Oka, Yoshiko Egi
1Division of Child Neurology, Institute of Neurological Science, Faculty of Medicine, Tottori University, Yonago, Japan.
Insights
Thiamine-responsive congenital lactic acidosis in infants can impair multiple metabolic pathways despite normal pyruvate dehydrogenase complex activity. Early thiamine therapy is crucial to prevent brain damage.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Congenital lactic acidosis is a group of inherited metabolic disorders.
- Thiamine-responsive congenital lactic acidosis (TR-CLA) presents with elevated lactate and pyruvate levels.
- The specific metabolic defects in TR-CLA are not fully understood.
Observation:
- Six infants with TR-CLA and normal in vitro pyruvate dehydrogenase complex activity were studied.
- Elevated urinary excretion of alpha-ketoglutarate, alpha-ketoadipate, and branched-chain ketoacids was observed.
- Transport systems (THTR-1, THTR-2) and thiamine pyrophosphokinase (hTPK1) showed no abnormalities.
Findings:
- Functional impairment of multiple thiamine-dependent enzymes, including pyruvate dehydrogenase complex, alpha-ketoglutarate dehydrogenase complex, and branched-chain amino acid dehydrogenase, was indicated.
- Despite normal activity of key enzymes in vitro, in vivo metabolic dysfunction was evident.
- No genetic defects were found in thiamine transport or pyrophosphorylation.
Implications:
- Early diagnosis and prompt thiamine administration are critical to prevent irreversible neurological damage in infants with TR-CLA.
- Monitoring lactate and pyruvate levels can aid in optimizing thiamine dosage.
- Further research into the precise mechanisms of thiamine metabolism in TR-CLA is warranted.
Abstract:
We studied six infants with thiamine-responsive congenital lactic acidosis and normal pyruvate dehydrogenase complex activity in vitro, through clinical and biochemical analysis. In addition to elevated lactate and pyruvate levels, the data revealed increased urinary excretion of alpha-ketoglutarate, alpha-ketoadipate, and branched chain ketoacids, indicating functional impairment of thiamine-requiring enzymes, such as pyruvate dehydrogenase complex, alpha-ketoglutarate dehydrogenase complex, alpha-ketoadipate dehydrogenase, and branched chain amino acid dehydrogenase. The metabolism of thiamine has not been investigated in patients with thiamine-responsive congenital lactic acidosis. We evaluated two specific transport systems, THTR-1 (SLC19A2) and THTR-2 (SLC19A3), and a pyrophosphorylating enzyme of thiamine, thiamine pyrophosphokinase (hTPK 1), in addition to pyruvate dehydrogenase complex and alpha-ketoglutarate dehydrogenase complex activity; no abnormality was found. Although the clinical features of thiamine-responsive congenital lactic acidosis are heterogeneous and clinical responses to thiamine administration vary, we emphasize the importance of early diagnosis and initiation of thiamine therapy before the occurrence of permanent brain damage. Careful monitoring of lactate and pyruvate would be useful in determining thiamine dosage.
More Related Videos
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
06:48Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
Related Concept Videos
Inborn Errors of Metabolism
Lysosomal Hydrolases
Amino Acid Biosynthetic Pathways